Skip to content

Penn’s health system had $88 million in operating profit for three months ended Sept. 30

The nonprofit health system had solid growth in revenue and patient volumes, but higher expenses led to lower operating profit compared to a year ago.

Pennsylvania Hospital in Center City is part of the University of Pennsylvania Health System, which reported $88 million operating income for the three months that ended Sept. 30.
Pennsylvania Hospital in Center City is part of the University of Pennsylvania Health System, which reported $88 million operating income for the three months that ended Sept. 30.Read moreHarold Brubaker / Staff

The University of Pennsylvania Health System reported significantly lower operating profit in the quarter that ended Sept. 30 compared to a year ago, as increased expenses outpaced revenue growth.

The seven-hospital system anchored by the Hospital of the University of Pennsylvania had $88 million in operating income in the first quarter of fiscal 2027, down from $109 million a year ago, according to a report to municipal bond investors this week.

“We had very good growth on the inpatient and outpatient side that is generating higher revenue for us,” the health system’s chief financial officer Julia Puchtler said Wednesday. She cited higher employee benefit costs and medical malpractice expenses as key offsetting factors.

Here are more details:

Revenue: Penn’s quarterly revenue climbed 8.7%, to $3.6 billion from $3.3 billion. Patient volumes, adjusted to include both inpatient and outpatient business, rose to 99,400 from 95,800, Puchtler said. The notable growth areas include chemotherapy. Penn expanded its infusion center in Lancaster County over the summer because it was full, despite Penn’s push to do more chemotherapy at home, she said.

Expenses: Employee benefit expenses jumped 17% to more $400 million in the quarter as the health system’s more than 50,000 employees used more medical services and pharmaceuticals, Puchtler said. Those increases started in the second half of the last fiscal year, she said. Medical malpractice expense for the latest quarter jumped to $46.5 million from $38.7 million.

Notable: Medicare changes, including a significant revamp to a federal drug discount program known as 340(b), that take effect Jan. 1 are expected to cost Penn from $50 million to $100 million annually, Puchtler said. Payments reductions for certain imaging services at outpatient departments that are not on the hospital campus but treated as if they are for billing purpose will also impact Penn’s finances. “We’re already underway with work to mitigate” this hit, Puchter said.